Hemodynamic Instability, Pain
Conditions
Keywords
pain, Virtual reality glasses, open heart surgery, hemodynamic
Brief summary
In this study, between 1 January 2025 - 1 June 2025, who met the inclusion and exclusion criteria, a total of 82 patients who are on the 2nd or 3rd day after the surgery and who are hospitalized in the cardiovascular surgery intensive care clinic will be recruited.
Detailed description
The patient will be put on virtual reality glasses five minutes before the chest tube is removed. Afterwards, it will continue to be watched while the tube is taken and virtual reality glasses will be watched for another five minutes. Pain level and hemodynamic variables will be checked before, during, and 15 and 30 minutes after virtual reality glasses are watched. The participants in the control group will receive routine treatment and care, and their data will be collected at the same time as those in the study group. Hemodynamic variables will be monitored and recorded on the monitor. Virtual reality glasses application is a method without any side effects. During the research, any adverse condition (vision problem, nausea, dizziness, etc.) related to the use of virtual glasses will be observed by the researcher. Since virtual reality glasses will be used in another patient after being used on one patient, disinfection will be made in line with the company's recommendations, taking into account the pandemic conditions. Throughout the application, feedback will be received from the patients by the researchers.
Interventions
OTHERvirtual reality
Virtual reality glasses application is a method without any side effects. Patients will be treated for an average of 10 minutes. Data will be collected before, during, immediately after the application, at the 15th and 30th minutes.
Sponsors
Mersin University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Intervention model description
The study was planned as a prospective, two-armed (1:1), randomized controlled experimental study. This randomized controlled trial will be reported according to the CONSORT guidelines.
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Agreeing to participate in the research (signing the Informed Consent Form), * Conscious and cooperative, * Stable hemodynamic status, * Speaks and understands Turkish, * Over 18 years old, * On the 2nd and 3rd day after open heart surgery, * Having chest tube, * No sensitivity or trauma in the area (for the study group) where the virtual reality glasses will be applied, * No active COVID-19 infection, * Patients without any psychiatric diagnosis
Exclusion criteria
* Agreeing to participate in the research (signing the Informed Consent Form), * Not conscious, * Not cooperative * Unstable hemodynamic status, * Speaks and understands Turkish, * who are under the age of 18, * On the 0th or 1st day after surgery, * No chest tube, * Has sensitivity or trauma in the area (for the study group) where the virtual reality * Active COVID-19 infection, * Patients with a psychiatric diagnosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain evaluated using the Visual Analogue Scale | Change from before implementation up to 30 minutes | Visual Analogue Scala has been developed to convert some values that cannot be measured numerically into numeric values. The VAS, which is a safe and easily applicable scale tool generally accepted in the world literature, consists of a 10 cm long line and there are subjective descriptive expressions at both ends of the scale (0 cm = none at all and 10 cm = highest degree.) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Systolic blood pressure | Change from before implementation up to 30 minutes | Systolic blood pressure (SBP), mmHg |
| Diastolic blood pressure | Change from before implementation up to 30 minutes | Diastolic blood pressure (DBP), mmHg |
| Heart rate | Change from before implementation up to 30 minutes | Beats per minute |
| Respiratory rate | Change from before implementation up to 30 minutes | Lung breathing |
| Peripheral oxygen saturation | Change from before implementation up to 30 minutes | %, percentage of oxygenated hemoglobin in peripheral arterial blood |
Countries
Turkey (Türkiye)
Outcome results
None listed